ARCHIVES

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: “…In Case Mrs. Lasker Happens To See A Senator”; White Potter Defend Center Progress

June 16, 1978

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994

Also Kevin Cullen named director, Univ. of Maryland Greenebaum Cancer Center.

November 28, 2003

Hawaiian Have Highest Cancer Rate In U.S.

April 29, 1983

Possible Government Shutdown Looms Over Biomedical Research Funding Once More

September 23, 2011